Skip to content

Evaluation after informed consent

Evaluation after informed consent - EVARS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00000743
Enrollment
48
Registered
2011-03-22
Start date
2011-07-05
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Indication various

Interventions

Group 1: Questionnaire for clinicians and patients

Sponsors

Studienzentrum des Universitätsklinikums Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Clinicians: - Persons who obtain informed consent - Written informed consent Patients: - Age = 18 years - Persons after a informed consent for an actual clinical trial - Persons with legal capacity who is able to understand the nature, significance and consequences of the communication study - Written informed consent

Exclusion criteria

Exclusion criteria: Clinicians: - Persons who are in a relationship of dependence with the investigator - Persons who had already participated in this study Patients: - Persons where a power-of-attorney for health care is to be given - Known or persistent abuse of medication, drugs or alcohol - Persons who are in a relationship of dependence with the investigator

Design outcomes

Primary

MeasureTime frame
How easy can clinicians appraise their patients regarding their reasons for or against participating in an actual clinical trial? Data will be collect by a questionnaire. This questionnaire has to be filled in by clinicians and patients after informed consent.

Secondary

MeasureTime frame
Is the concordance between reasons, patients have for or against participating in a clinical trial and reasons clinicians assume they have depending on - how well the clinicians know the patients? - the time clinicians are on duty? - number of attending communication skills courses? Data will collect by a questionnaire which clinicians have to fill in after informed consent.

Countries

Germany

Contacts

Public ContactBirgit Grotejohann

Studienzentrum des Universitätsklinikums Freiburg

birgit.grotejohann@uniklinik-freiburg.de+49 (0) 761 270 74000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026